SK12798A3 - Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use - Google Patents
Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use Download PDFInfo
- Publication number
- SK12798A3 SK12798A3 SK127-98A SK12798A SK12798A3 SK 12798 A3 SK12798 A3 SK 12798A3 SK 12798 A SK12798 A SK 12798A SK 12798 A3 SK12798 A3 SK 12798A3
- Authority
- SK
- Slovakia
- Prior art keywords
- pyridin
- prop
- enyl
- tolyl
- methylimidazo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9516115.4A GB9516115D0 (en) | 1995-08-05 | 1995-08-05 | Imidazopyridine derivates |
GBGB9608592.3A GB9608592D0 (en) | 1996-04-24 | 1996-04-24 | Imidazopyridine derivatives |
PCT/GB1996/001849 WO1997006167A1 (en) | 1995-08-05 | 1996-07-30 | Imidazopyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SK12798A3 true SK12798A3 (en) | 1998-08-05 |
Family
ID=27267850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK127-98A SK12798A3 (en) | 1995-08-05 | 1996-07-30 | Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use |
Country Status (10)
Country | Link |
---|---|
US (1) | US5866588A (pt) |
EP (1) | EP0842175A1 (pt) |
JP (1) | JPH11510180A (pt) |
AU (1) | AU698487B2 (pt) |
BR (1) | BR9609892A (pt) |
GB (1) | GB2308593B (pt) |
MX (1) | MX9707187A (pt) |
NZ (1) | NZ313726A (pt) |
SK (1) | SK12798A3 (pt) |
WO (1) | WO1997006167A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
CN1823051B (zh) * | 2003-07-14 | 2010-07-07 | 宇部兴产株式会社 | 4-氨基四氢吡喃化合物及其酸盐的制造方法、其合成中间体及其制造方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU44821B (en) * | 1982-02-04 | 1991-02-28 | Wellcome Found | Process for obtaiing new pyridyl derivatives |
US4621094A (en) * | 1983-03-10 | 1986-11-04 | Findlay John W A | Anti-histaminic pyridyl compounds |
GB9102997D0 (en) * | 1991-02-13 | 1991-03-27 | Pfizer Ltd | Therapeutic agents |
GB9107398D0 (en) * | 1991-04-09 | 1991-05-22 | British Bio Technology | Compounds |
-
1996
- 1996-07-30 WO PCT/GB1996/001849 patent/WO1997006167A1/en not_active Application Discontinuation
- 1996-07-30 NZ NZ313726A patent/NZ313726A/en unknown
- 1996-07-30 SK SK127-98A patent/SK12798A3/sk unknown
- 1996-07-30 BR BR9609892A patent/BR9609892A/pt not_active Application Discontinuation
- 1996-07-30 US US08/849,980 patent/US5866588A/en not_active Expired - Fee Related
- 1996-07-30 EP EP96925892A patent/EP0842175A1/en not_active Withdrawn
- 1996-07-30 MX MX9707187A patent/MX9707187A/es unknown
- 1996-07-30 AU AU66254/96A patent/AU698487B2/en not_active Ceased
- 1996-07-30 JP JP9508210A patent/JPH11510180A/ja active Pending
- 1996-07-30 GB GB9708363A patent/GB2308593B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH11510180A (ja) | 1999-09-07 |
GB2308593B (en) | 1999-01-27 |
AU6625496A (en) | 1997-03-05 |
EP0842175A1 (en) | 1998-05-20 |
MX9707187A (es) | 1997-11-29 |
NZ313726A (en) | 1998-11-25 |
US5866588A (en) | 1999-02-02 |
AU698487B2 (en) | 1998-10-29 |
GB2308593A (en) | 1997-07-02 |
GB9708363D0 (en) | 1997-06-18 |
WO1997006167A1 (en) | 1997-02-20 |
BR9609892A (pt) | 1999-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4592077B2 (ja) | 嘔吐、抑鬱、不安および咳の処置のためのニューロキニン−1(nk−1)アンタゴニストとしての1−アミド−4−フェニル−4−ベンジルオキシメチル−ピペリジン誘導体および関連化合物 | |
JP5767631B2 (ja) | バニロイド受容体リガンドとしての置換された芳香族カルボキサミドおよび尿素誘導体 | |
TWI491595B (zh) | 作為香草類化合物受體之配體之經取代苯基尿素及苯基醯胺 | |
JP4054369B2 (ja) | オルト置換アリールまたはヘテロアリールアミド化合物 | |
CN103772239B (zh) | 酰胺和脒衍生物和其用途 | |
JP2008540597A (ja) | 置換されたべンゾ[d]イソオキサゾール−3−イル−アミン−化合物及バニロイド受容体リガンドとしてのその使用 | |
JP2013545740A (ja) | バニロイド受容体リガンドとしての置換された複素芳香族カルボキサミド誘導体および尿素誘導体 | |
JP5617919B2 (ja) | テトラヒドロベンゾチオフェン化合物 | |
US8642775B2 (en) | Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions | |
CN107108593B (zh) | 作为类香草素受体配体ii的基于取代的恶唑和噻唑的羧酰胺和脲衍生物 | |
MXPA06002551A (es) | Compuestos de aril o heteroaril amida. | |
WO2007017093A1 (en) | Substituted 2-benzyloxy-benzoic acid amide derivatives | |
WO2007017092A1 (en) | Substituted 4-benzyloxy-benzoic acid amide derivatives | |
DE19730989A1 (de) | Piperazin-Derivate | |
JP2014521618A (ja) | 置換複素環アザ誘導体 | |
US6127343A (en) | Somatostatin agonists and antagonists | |
JP2013534229A (ja) | バニロイド受容体リガンドとしての置換された環状カルボキサミド誘導体および尿素誘導体 | |
EP1539724A1 (en) | Amino benzothiazole compounds with nos inhibitory activity | |
JP2014521617A (ja) | バニロイド受容体リガンドとしての置換二環性芳香族カルボキサミドおよび尿素誘導体 | |
US5753671A (en) | Imidazopyridine derivatives as dual histamine (H1) and platelet activating factor (PAF) antagonists | |
JP2014518281A (ja) | 電位依存性ナトリウムチャネル遮断薬 | |
KR950014568B1 (ko) | 융합된 이미다조헤테로사이클릭 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
SK12798A3 (en) | Imidazopyridine derivatives, method for producing thereof, pharmaceutical composition containing same and their use | |
US6159941A (en) | Use of somatostatin agonists and antagonists for treating diseases related to the eye | |
EP3130589A1 (en) | Heterocyclic aza compounds |